Plant polyphenols have been the subject of several recent scientific investigations since many of the molecules in this class have been found to be highly active in the human body, with a plethora of healthpromoting activities against a variety of diseases, including heart disease, diabetes, and cancer, and with even the potential to slow aging. Further development of these potent natural therapeutics hinges on the formation of robust industrial production platforms designed using specifically selected as well as engineered protein sources along with the construction of optimal expression platforms. In this work, we first report the investigation of various stilbene synthases from an array of plant species considering structure-activity relationships, their expression efficiency in microorganisms, and their ability to synthesize resveratrol. Second, we looked into the construct environment of recombinantly expressed stilbene synthases, including different promoters, construct designs, and host strains, to create an Escherichia coli strain capable of producing superior resveratrol titers sufficient for commercial usage. Further improvement of metabolic capabilities of the recombinant strain aimed at improving the intracellular malonyl-coenzyme A pool, a resveratrol precursor, resulted in a final improved titer of 2.3 g/liter resveratrol.
Resveratrol (3,5,4Ј-trihydroxy-trans-stilbene) is a polyphenolic compound that belongs to the stilbene class and is commonly found in red wine (up to 6.8 mg/liter), bushberries, peanuts, cranberries, other vine plants, and even trees and ferns. Resveratrol is speculated to be responsible for a decreased risk of heart disease and diabetes. Often called the "French paradox," the high intake of saturated fat, affected by levels of radical scavengers such as resveratrol, has been shown to correlate with a low mortality rate (8, 28 ). Yet, resveratrol may have additional health benefits, as numerous studies have found that its biological activities include antioxidative, antiinflammatory, anticancer, and chemopreventive abilities (6, 10, 14) . However, the most interesting activity attributed to resveratrol may be its potential to slow the aging process and prolong life spans, as seen in a variety of evolutionarily distant species, including Saccharomyces cerevisiae, Caenorhabditis elegans, Drosophila melanogaster, mice, and vertebrate fish (2, 13, 30, 35) . Nevertheless, there are contradicting results stating that the life span elongation is not due to resveratrol itself but due to a synergistic action of resveratrol with a fluorophoresignaling molecule (5, 24) .
The universal polyphenol biosynthetic pathway begins with the formation of phenylpropanoic acids from the aromatic amino acid phenylalanine or tyrosine or both. The phenylpropanoate is then activated by ligation to coenzyme A (CoA) by coumarate:CoA ligase, often acting only in the presence of a 4Ј-hydroxy group on the phenyl ring and thus termed 4-coumaroyl:CoA ligase (4CL). Polyphenols are then diversified by the type III polyketide synthases (PKSs), such as stilbene synthase (STS) for stilbene (i.e., resveratrol) synthesis and chalcone synthase (CHS) for flavonoid synthesis. In the pathway-committing step, PKSs act to condense successive units of malonyl-CoA with coumaroyl-CoA, forming a linear polyketide molecule before a cyclization reaction is carried out by the same PKS. For STS, 3 units of malonyl-CoA are used in the chain lengthening and a C2 to C7 aldol cyclization is used to form stilbenes ( Fig. 1) , while flavonoids are formed via a C6 to C1 Claisen reaction by CHS.
Two significant aspects of natural resveratrol formation hamper its application as a widespread nutraceutical. First, even in plants possessing the most abundant levels of resveratrol, this compound is produced in only trace amounts. For instance, peanuts and grapes contain no more than 4 g/g of dry plant matter and red wines contain an average of 2 mg/liter, yet the antiaging effects seen in mice are achievable only with biologically active dosages nearly 50 times that found in wine (3, 27) . Second, the biologically active form of resveratrol is the trans isomer. However, isolation from plants, as for many natural products, yields a mixture of multiple isomers and substituted forms, including cis, trans, and various less-active glycosylated forms (3, 18) . While recently transgenic stilbene production has been achieved in commonly consumed plant species (7, 12) , titers have remained low, making the biosynthesis of resveratrol an ideal target for microbial fermentation. This is because the method is easily scaled to commercial application, unlike methods using plant cell cultures, which have general limitations in cell development control, tissue specificity, uniform inducibility, and promoter strength. Furthermore, bacterial fermentations overcome many of the challenges associated with traditional chemical synthesis, specifically, the use of a toxic catalyst and the significant formation of by-products and various isomers at each synthetic step.
Previous efforts to engineer microorganisms for stilbene biosynthesis have resulted in relatively low production titers (17, 25, 34) , and little effort has been made to "tune" expression constructs or explore different STS proteins to improve production levels. In this study, we examine multiple constructs for resveratrol production by varying the "construct environment" through the use of different Escherichia coli strains (BL21 Star and BW27784), different promoter systems (specifically the strong T7 promoter and the constitutive promoter of the glyceraldehyde-3-phosphate dehydrogenase [GAPDH] gene), different gene expression combinations, and a library of isolated 4CLs and STSs. Additionally, we describe a more detailed investigation of stilbene biosynthesis in microorganisms by conducting both sequence analysis and protein-structure analysis as well as biochemical comparisons using a selection of stilbene synthases to identify highly active recombinant enzymes. With these optimization efforts, high production titers of resveratrol were achieved at grams per liter scale from p-coumaric acid.
MATERIALS AND METHODS
Strains and media. E. coli BL21 Star (Invitrogen) and strain BW27784 (E. coli Genetic Stock Center, New Haven, CT) were used for plasmid cloning and recombinant molecule production. DNA manipulations were performed according to standard recombinant DNA procedures (29) . Restriction enzymes and T4 DNA ligase were purchased from New England BioLabs. All PCR amplification and cloning reactions were performed using Accuzyme DNA polymerase (Bioline). Quantitative reverse transcription-PCR (qRT-PCR) was performed using the iScript with the SYBR green RT-PCR kit from Bio-Rad. Plasmid DNA was prepared from stock strains using a Zyppy plasmid miniprep kit, while fragment DNA was isolated by gel extraction using a Zymoclean gel DNA recovery kit (Zymo Research). Protein concentrations were measured using a bicinchoninic acid (BCA) assay kit (Pierce Scientific) with bovine serum albumin (BSA) as the standard. Plasmid-bearing cultures were grown in media containing, when needed, ampicillin (70 g/ml), kanamycin (40 g/ml), chloramphenicol (20 g/ ml), and/or streptomycin (40 g/ml). p-Coumaric acid, malonyl-CoA, coenzyme A, ATP, and the resveratrol standard were all purchased from Sigma-Aldrich, while cerulenin was purchased from Cayman Chemical. Coumaroyl-CoA was prepared according to the previously published method (32) .
Sequence analysis. A BLAST search of the National Center of Biotechnology Information (NCBI) nucleotide data bank identified numerous sequences predicted to encode stilbene synthases. From this search, the initial phylogenetic trees were constructed using MEGA4 to identify groupings of stilbene synthases. For both mRNA and protein sequences, minimum evolution trees were used with 500 bootstrap replicates and gamma distributed rates of change for each site (gamma parameter ϭ 1.0). For mRNA, a Tamura 3-parameter model was used with heterologous rates of mutation, while protein trees used a Poisson model and homogenous rates of change. A sample of stilbene synthases across the tree was then sent to be codon optimized and synthesized (Epoch Biolabs). The accession numbers for those sequences are as follows: Pinus strobus STS (PsSTS), Z46915; Pinus massoniana (PmSTS), DQ647829, Pinus densiflora STS (PdSTS), AB030140; Psilotum nudum STS (PnSTS), AB022685; Polygonum cuspidatum STSs, DQ459350 (Pcu1STS) and EF090266 (Pcu3STS). In addition, the mRNAs for the STS of Vitis vinifera (VvSTS) and Arachis hypogaea (AhSTS) were isolated from seedlings using a Qiagen RNeasy isolation kit, converted to cDNA by RT-PCR using Taq polymerase (New England BioLabs), and then purified. For AhSTS and VvSTS, the accession numbers for primer designs are A00769 and DQ459351, respectively. Homology modeling was performed using the SwissPdbViewer (Swiss Institute of Bioinformatics) (11) , with images and further analysis done using MacPyMol (DeLano Scientific).
Plasmid construction. Plasmids pACYCDuet-1 and pCDFDuet-1 were purchased from Novagen, while plasmid pUC18 containing the Arabidopsis thaliana 4CL (At4CL) and VvSTS genes downstream of the gap promoter (pGAP) was provided by Evonik Degussa. Plasmids pA-ACC and pCO-BirA were provided by M. A. G. Koffas laboratory stocks. The construction of pCDF was done by first cloning the Petroselinum crispum 4CL (Pc4CL) gene into the first multiple cloning site via EcoRI/SalI. Subsequently, STS genes were amplified and cloned via either BglII/PacI or NdeI/PacI. For amplification of the resveratrol biosynthesis pathway in pUC18, STS genes were cloned between either XbaI/NotI (V. vinifera), XbaI/PstI (A hypogaea), XbaI/NdeI (P. strobus), or XbaI/StuI (P. densiflora and P. massoniana) sites, while 4CL genes were cloned between two NotI sites. Only two STS genes were combined with the Pc4CL gene on one vector. For construct pUCo-AhSTS-Pc4CL, the AhSTS gene was cloned between XbaI/PstI sites, while the Pc4CL gene was cloned between PstI/NotI sites. For constructing pUCo-VvSTS-Pc4CL, the VvSTS gene was cloned between XbaI/NotI sites, while For the isolation of purified proteins, N-terminal 6-histidine-tagged protein fusions were made for each STS in pACYCDuet-1. This was done by PCR amplification of each STS gene using restriction tail primers and cloning between AcsI and SalI restriction sites downstream of the T7 promoter (pT7). Constructs were confirmed by both restriction digest screening and sequencing before transformation into E. coli BL21 Star for expression. All plasmids used in this study are listed in Table 1 .
Protein purification. To isolate purified STS proteins, E. coli BL21 Star cultures harboring the STS His-tagged constructs were grown in LB broth at 37°C until the optical density (OD) reached 0.6. Cultures were then induced with 1 mM isopropyl-␤-D-thiogalactopyranoside (IPTG) and grown at 30°C for another 4 h. Cells were then harvested by centrifugation, washed with ice-cold binding buffer (20 mM sodium phosphate, 500 mM sodium chloride), and reduced in volume 50-fold. Cells were then sonicated at 4°C for a total of 1 min (15-s pulses) and then centrifuged for 20 min at 14,000 rpm on a precooled benchtop microcentrifuge. Next, samples were pooled and passed through a 0.22-m syringe filter as crude extract. After the HisTrap column was washed (1 ml; GE Healthcare) with sterile deionized (DI) water and equilibrated with 5 column volumes (CV) of binding buffer, the crude soluble proteins were applied to the column at a flow rate of 1 CV per minute. Elution was carried out using 5 CV for each step in a three-step profile with increasing concentrations of imidazole (30 mM, 100 mM, and 250 mM), collecting 1.0-ml fractions during the elution. The column was then stripped and regenerated according to the manufacturer's instructions. Each elution fraction was tested for the presence of proteins using a BCA assay (Pierce), with positive fractions pooled. Purified proteins were then passed through a Microcon YM10 column (Millipore), and buffer was changed to an assay buffer (20 mM HEPES, 5 mM EDTA). These purified proteins were then remeasured to verify purified protein concentration. All His-STS proteins were found in the first three fractions of the 250 mM elution. Transcription analysis. Primers used for qRT-PCR runs can be found in the supplemental material. To have a direct comparison between the constitutive pGAP expression and the inducible pT7 expression, all strains harboring the pT7 construct with 4CL and STS coding sequences in one bicistronic operon were grown with IPTG at all stages. To isolate RNA from all strains, preinoculums were grown overnight, then diluted to OD of 0.05 in 25 ml of fresh LB culture. After incubation at 37°C until the OD reached 0.6, cells were harvested for RNA isolation using the RNeasy isolation kit (Qiagen) according to the manufacturer's instructions.
Resveratrol fermentations. For E. coli strain BL21 Star, harboring the genes encoding the stilbene biosynthetic pathway in the pCDF plasmid, preinoculums were grown overnight in LB broth, then diluted to OD of 0.1 in 25 ml of fresh LB. Cells were incubated at 37°C until the OD reached 0.8 before they were induced with 1 mM IPTG and grown for another 3 h at 30°C for protein production. Next, cells were collected by centrifugation and resuspended in M9 medium containing the necessary antibiotics, 1 mM p-coumaric acid, 1 mM IPTG, and/or 0.05 mM cerulenin. Incubation continued at 30°C for 32 h prior to analysis of the heterologous products. For strains expressing acetyl-CoA carboxylase and biotin ligase, 6 M biotin was added. For HPLC analysis, 500 l of fermentation samples was centrifuged and the supernatant was injected into the HPLC to quantify resveratrol levels. For strain BW27784, carrying the 4CL and STS genes in the pUC construct, the culture medium consisted of yeast extract M9 medium (YM9) adjusted to pH 7 (1ϫ M9 salts, 10 g/liter yeast extract, 3% glycerol, and 42 g/liter MOPS [morpholinepropanesulfonic acid] [Ͼ99.5% purity]) along with required antibiotics. Preinoculums were grown at 37°C for 6 h before being diluted to OD of 0.1 in 25 ml of fresh medium and grown overnight, again at 37°C. The next day, cells were collected by centrifugation and resuspended in fresh YM9 additionally supplemented with 15 mM p-coumaric acid, 10 g/liter of polyethylene glycol, and/or cerulenin. Incubation continued at 37°C for 24 h, and 100-l samples were collected at 6 and 24 h for analysis. A 100-l or sometimes 200-l (with high concentration of resveratrol) sample of ethyl acetate containing 1% HCl was added to each sample. The mixture was then vortexed for 30 s and separated through centrifugation before being injected into the HPLC.
HPLC analysis. For the pCDF system, cell-free culture medium from fermentations (100 l) was injected into the HPLC using a solvent profile with 0.1% (vol/vol) formic acid in acetonitrile (buffer A) and 0.1% (vol/vol) formic acid in water (buffer B) as the mobile phases and a flow rate of 1.0 ml per minute. The mobile-phase composition profile was fixed at 65% buffer B and 35% buffer A for 4 min, with 30 s of postrun time allowed for column equilibration. The resveratrol peak was found to elute at 3.6 min under this solvent profile. For production in BW27784, as well as in vitro assays, 2 l of the ethyl acetate fraction was injected into the HPLC. Ethyl acetate extraction using twice the volume of culture sampled was done prior to the HPLC injection to prevent polyethylene glycol from the culture medium or protein in the in vitro assay from clotting up the guard column in the HPLC.
RESULTS

An initial resveratrol construct.
A strain design similar to that from work done previously by our group for flavonoid biosynthesis was used as the initial resveratrol production platform (9, 20) . This consisted of E. coli strain BL21 Star harboring plasmid pCDFDuet-1, encoding 4CL from Petroselinum crispum (parsley; Pc4CL) and STS from Arachis hypogaea (peanut; AhSTS). Previous studies revealed that Pc4CL had a more diverse substrate specificity than other 4CL enzymes (21) , while the STS from peanuts is well studied and known to be active when produced recombinantly in E. coli with broad substrate specificity (23, 31, 34) . p-Coumaric acid was supplemented as the precursor for the biotransformation rather than the basic amino acids for several reasons. First, both phenylalanine ammonia lyase (PAL) and tyrosine ammonia lyase (TAL) suffer from low turnover numbers. Another P450 enzyme, cinnamate-4-hydroxylase (C4H), catalyzing the conversion of cinnamic acid to p-coumaric acid, fails to be effectively expressed in E. coli. Moreover, p-coumaric acid is the second most abundant compound derived from lignin and is therefore relatively cheap. As a result, batch fermentation was able to achieve up to 33 mg/liter of resveratrol production in shake flask cultures.
Screening for new STS via bioinformatics and homology modeling. To further expand the production potential of this construct, it was hypothesized that a more active STS would increase production rates and levels. Therefore, an array of STS proteins was identified for testing. As a first step, an initial phylogenetic tree built from a BLAST search led to the selection of seven new STS sequences based on different tree groupings. Those selected include Vitis vinifera (wine grape; VvSTS), 2 sequences from Polygonum cuspidatum (Japanese knotweed; Pcu1STS and Pcu3STS), Psilotum nudum (whisk fern; PnSTS), Pinus massoniana (Chinese red pine; PmSTS), Pinus strobus (eastern white pine; PsSTS), and Pinus densiflora (Japanese red pine; PdSTS). After being realigned using their protein sequences, all STS enzymes used in this study were used to construct a new phylogenetic tree ( Fig. 2A) . Inspection of the protein alignment revealed a highly conserved active site with greater than 90% positional amino acid sequence identity (data not shown). On the other hand, regions downstream and adjacent to the residues involved in the hydrogen-binding domain show a large variance in conservation (Fig. 2C) .
To investigate this further, homology models were built for each of the STS proteins selected by mapping the translated amino acid sequence to the previously published peanut STS, a known highly active STS, crystal structure (PDB identification number 1Z1F). After homology models were built, a considerable variance in the hydrogen-binding domain compared to that of peanut STS was seen in VvSTS, PsSTS, PmSTS, PdSTS, and PnSTS (Fig. 3) . Specifically, Met98 (AhSTS numbering) has been changed to a variety of residues of both increasing and decreasing sizes as well as increased electron withdrawing abilities. In contrast, a significant difference is seen in the supporting residues for both Polygonum STSs compared to AhSTS (Fig. 3) . Phe265 is lost in Pcu3STS completely, while in Pcu1STS the Gly256 is changed to a Leu, which extends into the catalytic pocket.
Investigating the kinetics of the STS and 4CL library. The VvSTS gene was isolated from plant material, while the six remaining STS gene sequences were synthesized following codon optimization. Similar to that of AhSTS, other STS genes were simultaneously cloned into the second multiple cloning site of the pCDFDuet-1 vector, with the first being occupied by the Pc4CL gene. Functional expression of each STS gene was verified by fermentation. Out of all STSs, only two STSs in addition to the AhSTS produced resveratrol above detectable limits: VvSTS (0.7 mg/liter) and PsSTS (2.0 mg/liter) ( Table 2) . As a second validation of functional expression, crude E. coli extract, after expression of each STS gene under pT7 control in the pACYC vector, was separately mixed with another crude extract harboring an active Pc4CL (data not shown). This led to the identification of a new active STS from P. massoniana in addition to those previously verified. Other STS enzymes, while produced in significant amounts as verified by SDS-PAGE, failed to form resveratrol above detectable limits and were not investigated further.
The four active proteins were further characterized in vitro using Ni ϩ affinity column purification, a method previously used for STS protein purification (26) . Interestingly, various production levels were found for each STS in crude extracts, as seen in SDS-PAGE and Western blot analysis (Fig. 2B) . Following purification and a buffer exchange to remove excess imidazole, in vitro assays established the apparent kinetic parameters of each STS (Table 3 ). Corresponding to the levels of resveratrol in the respective host plant material, the k cat /K m ratios for AhSTS and VvSTS were significantly higher than those for PsSTS and PmSTS. Additionally, in vitro assays using purified STS were performed while varying the acetyl-CoA concentration to investigate any inhibitory effect. Significant reductions in production were seen for all STS enzymes tested when concentrations were above 1 mM, indicating a degree of inhibitory activity well above normal cellular levels of acetylCoA. Due to the complexity of the ping-pong kinetic system (substrate binding, three successive substrate condensations, and product cyclization and release), only the apparent inhibitory constants for competitive and noncompetitive inhibition are reported. Based on the enzyme kinetics, both VvSTS and AhSTS appeared to have higher turnover numbers than the other STSs, especially in the case of VvSTS, with catalytic turnover of almost twice as that of AhSTS. Surprisingly, this observation was not reflected in vivo with host strain BL21 Star, in which Pc4CL coupled with AhSTS (33 mg/liter) performed much better than when used with VvSTS (0.7 mg/liter). Another cloning approach, in which both 4CL and STS genes were cloned into the same operon under the control of a single pT7 promoter, was attempted (Fig. 4A) . In this case, partial activity of VvSTS can be recovered and resveratrol production (15.5 mg/liter) was greater than with AhSTS (0.1 mg/liter) ( Table 4) . Apart from variable STS proteins, 4CL diversification was also addressed. 4CL from Arabidopsis thaliana (At4CL1) was employed in addition to Pc4CL because At4CL1 was also shown to be functional in recombinant E. coli for flavonoid biosynthesis (34) . In the pT7 system, both 4CL proteins gave similar production levels, indicating that 4CL is able to efficiently convert the p-coumaric acid into its coumaroyl-CoA ester. This result implies that either the activity (or expression) of STS is not sufficiently high to consume the available ester or that the intracellular pool of malonyl-CoA is limited, thereby slowing the generation of resveratrol.
High-production resveratrol strains by changing the expression construct. The work of Watts et al. achieved significantly higher titers than our original construct using a high-copynumber vector and an E. coli strain that is deficient in arabinose transport (34) . Since STS and 4CL gene expression from the pCDF backbone, and thus resveratrol biosynthesis, are limited by the activity of the T7 RNA polymerase encoded on the chromosome of BL21 Star, a new expression construct using a constitutive promoter based on the expected metabolic state of the cells during the production phase was proposed. In contrast to the IPTG-inducible promoter (pT7) in the initial expression system, the constitutive gap promoter (pGAP) was selected as it is actively induced during fermentation on glucose as the carbon source, thus allowing the continuous transcription of both 4CL and STS genes. Additionally, the alternative strain BW27784 was used to improve the level of biomass during fermentations in an effort to enhance resveratrol titers. Two approaches, one in which both genes were expressed under the control of separate gap promoters and the other in which both were expressed in an operon, were again used to introduce the genes into new strain BW27784 in highcopy-number plasmid pUC18 (Fig. 4A) . Fermentation titers revealed the inefficiency of a two-promoter construct in this new expression system compared to the one with a bicistronic operon ( Table 4 ). The production of resveratrol in the pUC expression system using either Pc4CL or At4CL was much higher than that by the pCDF system. Interestingly, Pc4CL limited resveratrol production compared to At4CL in all of the pUC constructs (Table 4) . PmSTS, PsSTS, AhSTS, and VvSTS were all found to be active in shake flask fermentations when expression of the respective genes was coupled with At4CL gene expression in an operon, resulting in final volumetric production levels of 23.7 mg/liter, 61.5 mg/liter, 404 mg/liter, and 1,380 mg/liter, respectively ( Table 2 ). The last is the highest resveratrol titer reported to date and represents an astounding increase of more than 40-fold compared to that with the starting pC-Pc4CL-AhSTS construct in BL21 Star of merely 33 mg/liter. These results also confirmed the accuracy of the in vitro assay with purified proteins, in which the catalytic efficiency of VvSTS is higher than that of AhSTS and both of their k cat /K m values were significantly higher than those of PsSTS and PmSTS. In order to address the production discrepancy between the two systems and also among different 4CL-STS combinations, quantitative RT-PCR was performed with the use of the common housekeeping gene encoding GAPDH as a reference gene. Expression of either the 4CL or STS gene in each construct was compared to the transcription of the respective gene in the construct yielding highest resveratrol production, pUCoVvSTS-At4CL. As seen in Fig. 4B , the transcription of the 4CL gene relies heavily on the STS gene, to which it is coupled. Similar trends for the At4CL and Pc4CL genes can be observed in both the pCDF and pUC constructs. While the transcription of the STS genes is independent of the 4CL genes, the expression of the AhSTS gene in all the constructs is uniform and significantly lower than the expression of the VvSTS gene.
High-titer resveratrol strains by increasing the precursor supply. Additional modifications to the fermentative strategy and construct design were also attempted to further elevate resveratrol titers by improving the availability of malonyl-CoA according to prior results (19, 20) . As a simple means to increase the intracellular malonyl-CoA level, cerulenin, a specific inhibitor of the fabB-fabF gene products (Fig. 1) , was introduced to the fermentation postinduction. However, the addition of cerulenin is cost prohibitive for a production scale fermentation process; therefore, another metabolic engineering strategy was attempted, one that used the simultaneous overexpression of acetyl-CoA carboxylase (ACC) and biotin ligase (BirA) from Photorhabdus luminescens, allowing acetylCoA to be more effectively converted to malonyl-CoA.
In the pCDF system, both strategies were able to improve the overall resveratrol production of pC-Pc4CL-AhSTS (Table  5) . Cerulenin was able to increase production up to 2-fold to 65 mg/liter, while when ACC and BirA were overexpressed, the production increased to 46 mg/liter. For the pUC system, additional coumaric acid supplementation was needed (increased from 6 mM to 15 mM) to maintain a substrate driving force for the formation of resveratrol. Production as a result of the cerulenin treatment was improved to 2,340 mg/liter in the pUC system. Overexpression of ACC/BirA was not attempted in the pUC system, mainly due to the host strain, BW27784, which lacks DE3 prophage for T7 RNA polymerase expression.
Cell dynamics during resveratrol production. The engineered strain BW27784 harboring the STS gene from V. vinifera and the 4CL gene from A. thaliana on a pUC backbone was cultured in YM9 to monitor the cell growth rate, availability of substrate, and resveratrol production over the course of 24 h (Fig. 5) . A substrate concentration of 15 mM (2,462 mg/liter) was used due to the effective conversion of the substrate. Especially in the cerulenin-supplemented culture, only 200 mg/ liter, or less than 10% of the initial substrate concentration, remained at the end of the fermentation period. High levels of resveratrol production persisted over the 24-hour period for the strain, both with and without cerulenin, reaching maximums of 2,390 and 1,260 mg/liter with linear rates in the first 5 h of 250 mg/liter/h and 180 mg/liter/h, respectively.
DISCUSSION
Developing efficient production platforms for natural products requires the engineering of both proficient catalytic proteins and stable expression constructs in addition to proper host selection. In this work we explored different strategies that would lead to the construction of an effective resveratrol production platform. These included the identification of alternative stilbene synthases for recombinant production of resveratrol and the comparison of different strain environments and different expression constructs. Previous characterization efforts have revealed significant conservation of the active-site cavity between CHS and STS. Namely, there are three catalytic residues (His303, Asn336, and Cys164) responsible for transferring the carboxyl group and an adjacent proline residue (Pro375) critical for carrying out the cyclization of the polyketide (15, 16, 33) . Recently, studies of the peanut and pine STS crystal structures as well as an STS-like mutant CHS have identified three residues (Thr131, Thr132, and Met98) critical in mediating stilbene-forming aldol cyclization by connecting an active-site water molecule to a buried glutamate (Glu192) (1, 31) . It has been suggested that variation of this region may shift the water molecule away from Cys164, resulting in a loss of catalytic activity (31) . Conserved glycine residues (Gly255 and Gly256), by which substrates enter the catalytic space, have been shown to affect the chain length of the growing polyketide via steric hindrance (15) . Considering these residues, we compared and contrasted the isolated STS sequences we obtained, followed by an investigation of their impact on both catalytic turnover and functionality. Phylogenetic analysis suggested an evolutionarily close relationship between the STS proteins considered in this study. Protein structure analysis revealed that, while cross-species conservation is seen in the catalytic triad and cyclization residues, STS proteins varied significantly in the hydrogen-bonding domain used to transfer electrons from a water molecule to a buried glutamate residue. We hypothesize that these changes have altered the catalytic activities of the different STS proteins. For example, the lack of activity in PdSTS is most likely caused by the loss of a residue near Arg307, as this residue has been implicated as a proton acceptor (26) . Similarly, PnSTS contains three arginine residues, in place of only one in AhSTS, directly after Met98 (Fig. 3) , a residue greatly influenced by side chain charges. While enzyme activity of PmSTS shows a k cat and K m similar to those of VvSTS, meriting its selection for use in a stilbene production construct, Western blot analysis showed PmSTS to be produced at a considerably lower level than both VvSTS and AhSTS (Fig. 2B) . Due to the low k cat and K m determined for PsSTS during the in vitro trials and the lack or limited production for the remaining STS proteins screened, high-yield resveratrol production appears to be feasible only with the use of VvSTS or AhSTS. Recently, it was shown that Pcu3STS is actually a bifunctional enzyme with both chalcone synthase and benzalacetone synthase activity, with preference for the latter (22) .
Exploration of various expression constructs led to an efficient platform using a constitutive promoter and unique gene combination in E. coli. The a priori selection of an efficient strain background for a given expression construct continues to be a challenging task. In this study a large disparity between the T7 promoter system in E. coli BL21 Star and the gap promoter system in E. coli BW27784 was seen. One advantage of strain BW27784 was its ability to achieve and maintain high cell density (Fig. 5A ) without the need of concentrating the biomass prior to the actual biotransformation, as done previously for the production of other flavonoid compounds (17) .
In the T7 promoter system, only three active STSs were found: AhSTS, VvSTS, and PsSTS. However, PmSTS was shown to be active in vitro using crude extract and pure protein.
A possible explanation could be that production of PmSTS in vivo was below the limit detectable by HPLC. When the strain background was moved to BW27784, the pGAP expression increased more than 40-fold over that of the best construct in BL21 Star, indicating an inherent preference for the BW27784 genotype. The four STS proteins had a production range from 23.7 to 1,380 mg/liter. Production differences between AhSTS and VvSTS using the same construct are most likely due to a combination of the lower observed catalytic activity for AhSTS (Table 3 ) and the higher transcriptional efficiency for VvSTS (Fig. 4B) . In the pCDF system, results showed that resveratrol production using VvSTS was enhanced when VvSTS and Pc4CL were expressed in an operon while production associated with AhSTS was enhanced by a system in which each gene was expressed under the control of a separate promoter. However, when either At4CL or Pc4CL was coupled with VvSTS and expressed under the control of a separate T7 promoter, higher transcription of the VvSTS gene resulted in the reduction of the overall yield.
On the other hand, for the pUC system, the constitutive promoter pGAP was utilized and both 4CL and STS genes were continuously transcribed. One of the expected advantages of using an operon-based expression platform is that both genes can be transcribed together as a polycistronic mRNA strand and translated together in the cytoplasm to form a protein complex. By coupling both the more efficient VvSTS and At4CL, resveratrol production at 1.4 g/liter was attained. However, when both the genes were expressed by separate promoters, production was reduced 5-fold to 348 mg/liter, possibly due to unbalanced expression, which could result in an increased accumulation of the coumaroyl-CoA intermediate, which could either inhibit STS or prove detrimental to cell viability. A similar effect was observed in the pCDF system, in which the VvSTS gene coupled with the At4CL gene worked more efficiently in an operon than with separate promoters. Production by AhSTS in the pUC construct was second to that by VvSTS, while the production achieved using the remaining STS enzymes was significantly lower. This result was somewhat related to the enzyme efficiency data obtained from the in vitro assays.
In the case of 4CL, no significant productivity differences were seen in the pCDF system when Pc4CL was replaced with At4CL. However, in the pUC system both VvSTS and AhSTS coupled with At4CL were considerably more efficient in producing resveratrol than either STS when coupled with Pc4CL (Table 4 ). This can be explained by the role of the expression system in each construct. We postulated that in the pCDF system, which suffered from low resveratrol production, there was a buildup of the coumaroyl-CoA intermediate, which was not efficiently converted to the end product by the STS. Therefore, the efficiency of the 4CL was not reflected in the overall production; hence, the catalytic conversion rates of both 4CLs could not be compared. On the other hand, with the pUC system, STSs actively converted the intermediate to the end product, driving the need for both malonyl-CoA and the intermediate, which required the 4CL to be fully functional. Particularly in the case of VvSTS, with twice the catalytic turnover efficiency of AhSTS, an efficient 4CL is required for resveratrol production, with At4CL favored over Pc4CL.
Resveratrol production platform efficiency was further improved through the inhibition of fatty acid biosynthesis by cerulenin and by the overproduction of ACC/BirA (Table 5) . Both approaches were able to improve the production of resveratrol with BL21 Star pC-Pc4CL2-AhSTS by up to 2-and 1.4-fold, respectively. Even with the pUC system, in which resveratrol production was very efficient, malonyl-CoA remained a limiting factor. By the addition of 0.05 mM cerulenin to the cultivation broth, the resveratrol titer was further increased to 2.3 g/liter (1.4 g/liter without adding cerulenin), another astounding 64% improvement. Similarly, an increase in volumetric resveratrol productivity was observed (Fig. 5C) . Within the first 5 h, when product concentration increases almost linearly with time, cerulenin was able to improve volumetric productivity at a rate of approximately 70 mg/h. Previous efforts to engineer recombinant microbes for stilbene biosynthesis focused on the overexpression of pathway enzymes and diversification of the chemistry of stilbene compounds (4, 17, 25, 34) . However, these studies lack sufficient understanding of resveratrol biosynthesis on the molecular level, for example, the catalytic turnover of the pathway enzymes as well as their transcription and translation efficiencies, largely determined by the employed gene expression system. Our study demonstrated the construction of an optimized resveratrol production system in E. coli by screening genes along the stilbene biosynthetic pathway from various plant sources for highest enzyme activity. A few enzyme combinations of 4CL and STS were subsequently selected for further optimization, including the gene expression system, strain background, and malonyl-CoA availability. Production discrepancies among different enzyme combinations and expression systems were resolved by quantitative RT-PCR and Western blotting. Various metabolic engineering approaches presented in this paper are critical to achieve significant production of resveratrol, and such strategies are applicable not only to resveratrol but also other highly valued nutraceuticals and secondary metabolites.
